27.07.2022 • NewsSolvayHydrogen Peroxides

Solvay Plans US Electronic-grade Hydrogen Peroxide Plant

Solvay has announced plans to build a new plant in Casa Grande, Arizona, USA, for producing electronic-grade hydrogen peroxide. The investment in its seventh such unit has been prompted by growing demand from the US semiconductor industry.

The plant, which will be fully powered using renewable electricity, will convert hydrogen peroxide into an ultra-high purity grade to clean the silicon wafers necessary for making the semiconductors, which are essential components in electronic devices.

“This investment will grow our presence in the North American semiconductor market,” said CEO Ilham Kadri. “The new facility will help us to further tap into increasing demand from the domestic electronic industry, and our local customers will likewise gain even better access to our products and services. This will help us meet their increasing demand for chemicals that are essential for cleaning and etching large-scale integrated circuits and semiconductors.”

Solvay has bought 25 acres of greenfield land within Casa Grande’s Central Arizona Commerce Park and construction of the first production line is scheduled to begin in 2023. Future expansions will be built as needed to support customer demand. The facility will also create 30 full-time jobs.  

The Belgian group announced in March this year that it was exploring options to split into two publicly listed companies. If the plans proceed, the spinoffs will take effect in the second half of 2023. One of the spinoffs would include Solvay’s peroxides, soda ash, silica, specialty chemicals and Coatis businesses, while the other would comprise specialty polymers, composites and most of its solutions segment, which includes Novecare, technology solutions, aroma performance and oil & gas.

Author: Elaine Burridge, Freelance Journalist

© Solvay
© Solvay

Company

Logo:

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact







Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.